Atossa Therapeutics, Inc. ( ATOS) - Stock Earnings
ATOS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
ATOS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -10.9 million USD | — USD |
| 2026Q1 | -9.6 million USD | — USD |
| 2026Q2 | -8.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ATOS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.1 million USD | — USD |
| 2024 | -25.5 million USD | — USD |
| 2025 | -34.8 million USD | — USD |
| 2026 Est. | — | — |
ATOS
Price: $2.44
52 week price:
Earnings Per Share: -4.34 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 530800
Ebitda: -2.0 millionMarket Capitalization: 23.3 million